55687-11-1

Basic information

• Product Name: 2-Chloro-6-methoxyquinoxaline
• Synonyms: 2-Chloro-6-methoxyquinoxaline
• CAS NO: 55687-11-1
• Molecular Formula: C₉H₇ClN₂O
• Molecular Weight: 194.61768
• Mol File: 55687-11-1.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 297.3±35.0 °C(Predicted)
• Appearance: /
• Density: 1.333±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.91±0.30(Predicted)
• CAS DataBase Reference: 2-Chloro-6-methoxyquinoxaline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-6-methoxyquinoxaline(55687-11-1)
• EPA Substance Registry System: 2-Chloro-6-methoxyquinoxaline(55687-11-1)

Safety Data

• Hazardous Substances Data: 55687-11-1(Hazardous Substances Data)

Usage

General Description

2-Chloro-6-methoxyquinoxaline is a chemical compound with the molecular formula C9H7ClN2O. It is a quinoxaline derivative, which is a class of organic compounds often used in pharmaceuticals and agrochemicals. This specific compound is characterized by a chloro group and a methoxy group attached to a quinoxaline ring. It is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Additionally, it has potential applications in research and development for its unique chemical properties. 2-Chloro-6-methoxyquinoxaline has potential for further study and application in the pharmaceutical and agrochemical industries.

Upstream product

• 6295-06-3 butyl glyoxalate 
• 102-51-2 4-methoxy-1,2-phenylenediamine 
• 298-12-4 Glyoxilic acid 
• 924-44-7 glyoxylic acid ethyl ester 
• 59548-39-9 4-methoxyphenylene-1,2-diamine dihydrochloride 
• 55687-30-4 7-methoxyquinoxalin-2(1H)-one 
• 91192-32-4 6-methoxylquinoxalin-2(1H)-one 
• 91192-32-4 6-methoxyquinoxalin-2-ol 
• 55687-30-4 7-methoxyquinoxalin-2-ol 
• 31910-18-6 2,3-dihydroxy-6-methoxyquinoxaline 

Downstream Products

• 497967-47-2 6-methoxyquinoxalin-2-amine 
• 55687-04-2 6-hydroxy-2-chloroquinoxaline 
• 216699-83-1 2-Anilino-6-methoxy-quinoxaline hydrochloride 
• 1192813-60-7 N-(2,4-dimethoxybenzyl)-6-methoxyquinoxalin-2-amine 
• 1437281-35-0 4-(6-(2-fluoroethoxy)quinoxalin-2-yl)-N,N-dimethylaniline 
• 1437281-36-1 4-(6-(2-fluoroethoxy)quinoxalin-2-yl)aniline 
• 1437281-37-2 4-(6-(2-fluoroethoxy)quinoxalin-2-yl)-N-methylaniline 
• 1437281-39-4 4-(6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)quinoxalin-2-yl)-N,N-dimethylaniline 
• 1437281-40-7 4-(6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)quinoxalin-2-yl)aniline 
• 1437281-41-8 4-(6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)quinoxalin-2-yl)-N-methylaniline 
• 1437281-42-9 6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)-2-(p-di(tert-butoxycarbonyl)aminophenyl)quinoxaline 
• 1437281-43-0 tert-butyl (4-(6-(2-((tert-butyldimethylsilyl)oxy)ethoxy)quinoxalin-2-yl)phenyl)(methyl)carbamate 
• 1437281-44-1 2-((2-(4-(dimethylamino)phenyl)quinoxalin-6-yl)oxy)ethyl 4-methylbenzenesulfonate 
• 1437281-45-2 2-((2-(4-((di-tert-butoxycarbonyl)amino)phenyl)quinoxalin-6-yl)oxy)ethyl 4-methylbenzenesulfonate 

Relevant articles and documents

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Α 7 as intranuclear hydroxynicotinic acetylcholine receptor quinuclidines compd.

PROBLEM TO BE SOLVED: To provide ligands for the nicotinic α-7 receptor used for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.SOLUTION: The disclosure provides compounds of the specified formula I, including their salts, and compositions and methods using the compounds.

Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors

Compounds belonging to several scaffolds-quinazolines, quinolines and quinoxalines-were designed and synthesized as Raf kinase inhibitors. Scaffolds were assessed for in vitro BrafV600E inhibition, and overall kinase selectivity. Pharmacokinetic parameters for one of the scaffolds were also determined.